CBDYOTCMedicinal Chemicals & Botanical ProductsUS GAAP · USD

Target Group Inc.

Target Group Inc. is a U.S.-incorporated cannabis company with operations centered in Canada through its subsidiary Canary. The business is engaged in the cultivation, processing, and distribution of curated cannabis products for medical and adult-use recreational markets, with additional emphasis on wholesale, co-packaging, research, testing, and product development.

Liikevaihto3,9milj. USD
−41,1 %v/v
Nettotulos−1,4milj. USD
−947,1 %v/v

Tilikausi 2025 · muutos edellisvuodesta

Kehitys 2020–2025

02468milj. USD2020: 0,03 milj. USD20202021: 0,00 milj. USD20212022: 0,00 milj. USD20222023: 3,7 milj. USD20232024: 6,6 milj. USD20242025: 3,9 milj. USD20253,9
LiikevaihtoLiikevoitto (EBIT)

Liiketoiminta

Osuus liikevaihdosta
Cannabis cultivation40 %

Growing cannabis for medical and adult-use markets in Canada and selected U.S. jurisdictions.

Cannabis processing and distribution30 %

Processing harvested material into saleable cannabis products and distributing them to customers.

Wholesale and co-packaging20 %

Bulk supply and packaging services for cannabis and related consumer packaged goods.

Research, testing and product development10 %

Cannabinoid research, analytical testing, and development support for new products.

Asiakkaat

The company sells cannabis products to a concentrated customer base, including wholesale buyers and downstream cannabis customers in Canada. Its reported revenue also reflects sales into medical and adult-use recreational channels, with some U.S. sales where state law permits. Customer demand is driven by product availability, regulatory access, and the ability to supply curated cannabis formats at scale.

Wholesale cannabis buyers

Buy bulk cannabis supply and related services for resale or further processing.

Medical cannabis market

Purchases cannabis products for regulated therapeutic use in Canada and other legalized markets.

Adult-use recreational market

Buys cannabis products for consumer retail channels in legalized jurisdictions.

Co-packaging and CPG customers

Use the company's packaging and manufacturing capabilities for cannabis-related products.

Strategia

The company is positioning itself around wholesale, co-packaging, research, testing, and manufacturing capabilities rather than only retail-facing cannabis sales. This strategy is intended to broaden its role in the cannabis supply chain and support product development for regulated markets. Access to financing and long-term supply agreements are central to executing this model.

Expand wholesale and co-packaging capabilitiesKeskipitkä aikaväli

These activities can deepen customer relationships and diversify the business model.

Integrate research, testing, and manufacturingKeskipitkä aikaväli

Vertical integration can improve product control and support differentiated offerings.

Secure external financingLyhyt aikaväli

The business depends on capital to fund operations and development.

Maantiede

Target Group is a U.S.-incorporated company with its principal executive office in Hamilton, Ontario, and operating activity centered in Canada. Its subsidiary Canary leases a 44,000 square foot facility in Norfolk County, Ontario, which anchors production for medical and recreational cannabis. The company also references sales in the United States where state legislation permits cannabis activity, but Canada remains the core operating geography.

Riskit

The company faces financing risk because it has relied on equity and related-party debt to fund operations and development. It also operates in a heavily regulated cannabis industry, where licensing, legalization, and customer concentration can materially affect sales and execution. Supply agreements, management retention, and foreign exchange exposure add further operational uncertainty.

Järjestetty vakavuuden mukaan
Financing dependenceKorkea

The company has relied on equity and related-party debt and may need more capital.

Kohdistuu: Operations and development funding

Customer concentrationKorkea

Reported revenue has been concentrated among a small number of customers.

Kohdistuu: Revenue stability

Cannabis regulatory riskKorkea

Sales depend on legalization and state/provincial rules for cannabis activity.

Kohdistuu: Canada and selected U.S. jurisdictions

Supply agreement riskKeskitaso

The business needs long-term supply agreements for mineralized material.

Kohdistuu: Input availability and production continuity

Foreign exchange riskKeskitaso

Canadian operations create translation and transaction exposure versus U.S. reporting currency.

Kohdistuu: CAD/USD balances and expenses

Kirjanpito

Harkinnanvaraiset erät
Revenue recognition

Cannabis product sales can be concentrated and timing-sensitive across quarters.

Vaikutus: Quarterly comparability and reported revenue

Derivative and warrant liability valuation

Revaluation of warrants and convertible debt changes other income/expense.

Vaikutus: Net income volatility

Related-party balances

Loans and management fees owed to related parties are material liabilities.

Vaikutus: Liquidity and leverage presentation

Lease accounting

The leased 44,000 square foot facility creates recurring lease obligations.

Vaikutus: Operating expenses and balance sheet liabilities

Inventory and receivable allowances

Cannabis operations require judgment on collectability and inventory recoverability.

Vaikutus: Asset valuation and working capital

Julkisesti listattuja yhtiöitä, joilla on samankaltainen liiketoiminta.

Päivitetty: 29.4.2026